The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
![Netherlands Netherlands flag](https://www.greenhill.com/sites/default/files/niederland.gif)
Veen Bosch & Keuning
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Veen Bosch & Keuning, the largest book publisher in the Netherlands, on its sale to Simon & Schuster, one of the world’s preeminent publishing houses
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
illion Australia Pty Ltd
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advising Experian Plc, the world’s leading global information services company, on the acquisition of illion Australia Pty Ltd, one of Australasia's leading consumer and commercial credit bureaus
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
myHomecare Group
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advising Australian Unity on its acquisition of myHomecare Group
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Exit of Homesafe Equity Release Joint Venture
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Adviser to Bendigo and Adelaide Bank on the exit of its investment in the Homesafe Equity Release Joint Venture
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Clinigen Ltd’s portfolio of Established Medicines
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advised Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of a portfolio of Established Medicines to CNX Therapeutics, a UK-based European pharma company owned by Inflexion Partners
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Farmalider Group
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Advising the shareholders of Grupo Farmalider, a B2B Spanish pharmaceutical company focused on contract manufacturing, innovation and development of products based on generics, on the sale of an undisclosed stake to local private equity MCH
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Synfonium / Qwant / Shadow
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Advised Banque des Territoires / Groupe Caisse des Dépôts (CDC), a French Public Institution, on the investment in the newly created platform Synfonium, incorporating Shadow, a cloud-based platform, and Qwant, a sovereign search engine. CDC will hold a 25% stake in Synfonium, while Octave Klaba and Miroslaw Klaba, the co-founders of OVHcloud, will hold the remaining 75%
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Kyowa Kirin International’s testosterone replacement therapy drug, Tostran®
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on the divestiture of its testosterone replacement therapy drug, Tostran®, to Advanz Pharma, a privately-held, specialty pharmaceutical company
![](https://www.greenhill.com/sites/default/files/greece-uk.png)
Clinigen Ltd’s Lamda Laboratories
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Lamda Laboratories, a European contract development business, to Adragos Pharma, a Munich-based pharmaceutical CDMO
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Clinigen Ltd’s Proleukin
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Proleukin (Interleukin-2 (Aldesleukin)), to Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma
![](https://www.greenhill.com/sites/default/files/uk-japan.png)
Kyowa Kirin International’s established medicines business
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on a collaboration agreement with Grünenthal GmbH, a global, science-based, privately-owned pharmaceutical company
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
brsk
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising brsk, a UK-based alternative network broadband provider, on its first debt-raise of £178m from Ares Management, a leading global alternative investment manager
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Australian Executor Trustees
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advising Equity Trustees, one of Australia’s leading specialist trustee companies, on the acquisition of Australian Executor Trustees from Insignia Financial
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Wildstone
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Advising DigitalBridge, one of the largest global digital infrastructure investors, on the sale of Wildstone, Europe’s largest owner of independent outdoor media infrastructure, to Antin Infrastructure Partners
![Switzerland Switzerland flag](https://www.greenhill.com/sites/default/files/switzerland.gif)
Netrics Digital Infrastructure
![Netherlands Netherlands flag](https://www.greenhill.com/sites/default/files/niederland.gif)
Advising NorthC, the largest regional data center provider in the Netherlands, on their agreement to acquire the data centers and connectivity services of Netrics in Switzerland
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Netomnia
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Netomnia, a leading UK-based fiber operator, on its £295m fundraise led by DigitalBridge Investment Management with follow-on commitments from existing shareholders Soho Square Capital LLP and Advencap Limited
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Acacia Pharma Group plc
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Acacia, a UK-domiciled and Euronext-listed commercial stage biopharmaceutical company, on the sale to Eagle Pharmaceuticals, an integrated pharmaceutical company with R&D, manufacturing and commercial expertise
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Theramex
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Carlyle, the leading private equity investor, on the acquisition of Theramex, a Women’s health-focused specialty pharmaceutical company . The acquisition was jointly executed with PAI Partners
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Telxius Telecom
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Advising KKR, on the disposal of its 40% stake in Telxius Telecom, a global telecommunications infrastructure company, to a consortium formed by Telefónica and Pontegadea
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Akorn Pharmaceuticals Portfolio of Branded Ophthalmic Products
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Advised Akorn Pharmaceuticals, a specialty pharmaceuticals manufacturer and marketer, on the divestiture of its portfolio of branded ophthalmic products to Laboratoires Théa SAS
![Poland Poland flag](https://www.greenhill.com/sites/default/files/poland.gif)
Emitel S.A.
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advised Cordiant Digital Infrastructure Limited, a UK-listed Investment Trust, on the acquisition of Emitel S.A., a Polish telecom tower infrastructure business
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Netomnia
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised Netomnia, a UK-based fibre operator, on its first large-scale fundraise of £123m
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Kao Data Ltd
![New Zealand New Zealand flag](https://www.greenhill.com/sites/default/files/new-zealand_flag_40105.gif)
Advised Kao Data Ltd, which is jointly owned by Legal & General Group PLC and Noé Group subsidiary Hockham, on raising an initial £120m-£130m growth capital commitment from Infratil Ltd with the objective of creating a £500m data centre platform
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Faes Farma, flagship product Bilastine
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Faes Farma in the signing of a long-term license agreement for its flagship product Bilastine with Hikma Specialty USA INC, a subsidiary of Hikma Pharmaceuticals PLC, for the United States of America